Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Cardiovascular market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

424 Item(s)

Page 1 of 43

  1. Myocardial Fibrosis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Dec-2016
    , Product code: GMDHC8818IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis – Pipeline Review, H2 2016, provides an overview of the Myocardial Fibrosis (Cardiovascular) pipeline landscape.
    $2,000.00

  2. Hypertension - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Dec-2016
    , Product code: GMDHC8829IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.
    $2,000.00

  3. Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

    By: GBI Research
    , Published: Dec-2016
    , Product code: GBIHC426MR
    Hypertension is a serious and common medical condition characterized by elevated blood pressure. It is commonly seen in the aging population, and in people with sedentary lifestyles and obesity. As one of the most significant preventable causes of death worldwide, early diagnosis of the condition is crucial to improve health outcomes. Hypertension is the key risk factor for stroke; according to the National Stroke Association (NSA), two-thirds of patients who suffer a stroke have hypertension.
    $4,995.00

  4. Stroke - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8726IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) pipeline landscape.
    $2,000.00

  5. Behcet Disease - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8734IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease – Pipeline Review, H2 2016, provides an overview of the Behcet Disease (Immunology) pipeline landscape.
    $2,000.00

  6. Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8743IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape.
    $2,000.00

  7. Ventricular Tachycardia - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8749IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Pipeline Review, H2 2016, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape.
    $2,000.00

  8. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8750IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016, provides an overview of the Vaso-Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline landscape.
    $2,000.00

  9. Critical Limb Ischemia - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8647IDB
    Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease (PAD). It is caused by chronic inflammatory processes associated with atherosclerosis that result in reduced blood flow to the legs, feet and hands. Symptoms include pain or numbness in feet or toes, sores, skin infections will not heal. Treatment goals for CLI include reducing the number of cardiovascular risk factors (such as quitting smoking and reduction of cholesterol), relieving pain, healing ulcers, preventing major amputation, improving quality of life and increasing survival.
    $2,000.00

  10. Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8665IDB
    Peripheral vascular disease (PVD) refers to diseases of the blood vessels (arteries and veins) located outside the heart and brain. Symptoms include painful cramping in hip, thigh or calf muscles after activity, such as walking or climbing stairs (intermittent claudication), leg numbness or weakness, coldness in lower leg or foot, especially when compared with the other side, sores on toes, feet or legs that won't heal, slower growth of toenails and erectile dysfunction in men.
    $2,000.00

424 Item(s)

Page 1 of 43